Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Expert Rev Anti Infect Ther. 2022 Apr;20(4):631-641. doi: 10.1080/14787210.2022.2000860. Epub 2021 Nov 26.
The aim of this study is to evaluate the sex differential effect in the COVID-19 mortality by different age groups and polymerase chain reaction (PCR) test results.
In a multicenter cross-sectional study from 55 hospitals in Tehran, Iran, patients were categorized as positive, negative, and suspected cases.
A total of 25,481 cases (14,791 males) were included in the study with a mortality rate of 12.0%. The mortality rates in positive, negative, and suspected cases were 20.55%, 9.97%, and 7.31%, respectively. Using a Cox regression model, sex had a significant effect on the hazard of death due to COVID-19 in adult and senior male patients having positive and suspected PCR test results. However, sex was not found as significant factor for mortality in patients with a negative PCR test in different age groups.
Regardless of other risk factors, we found that the effect of sex on COVID-19 mortality varied significantly in different age groups. Therefore, appropriate strategies should be designed to protect adult and senior males from this deadly infectious disease. Furthermore, owing to the considerable death rate of COVID-19 patients with negative test results, new policies should be launched to increase the accuracy of diagnosis tests.
本研究旨在评估不同年龄组和聚合酶链反应(PCR)检测结果的 COVID-19 死亡率中的性别差异效应。
在伊朗德黑兰 55 家医院进行的一项多中心横断面研究中,将患者分为阳性、阴性和疑似病例。
共纳入 25481 例患者(男性 14791 例),死亡率为 12.0%。阳性、阴性和疑似病例的死亡率分别为 20.55%、9.97%和 7.31%。使用 Cox 回归模型,在阳性和疑似 PCR 检测结果的成年和老年男性患者中,性别对 COVID-19 死亡的危害有显著影响。然而,在不同年龄组的 PCR 检测结果为阴性的患者中,性别并不是死亡的显著因素。
无论其他危险因素如何,我们发现性别对 COVID-19 死亡率的影响在不同年龄组中存在显著差异。因此,应制定适当的策略来保护成年和老年男性免受这种致命传染病的侵害。此外,由于 COVID-19 阴性检测结果患者的死亡率相当高,应推出新政策以提高诊断检测的准确性。